Victory Capital Management Inc Ampio Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$0.08 - $21.0 $356 - $93,450	-4,450 Reduced 15.84%	23,635 $1,000
Q2 2022 Aug 01, 2022	SELL	$0.16 - $0.47 $80 - $237	-505 Reduced 1.77%	28,085 $5,000
Q1 2022 May 04, 2022	SELL	$0.42 - $0.62 $389 - $574	-927 Reduced 3.14%	28,590 $7,000
Q4 2021 Feb 07, 2022	BUY	$0.56 - $1.71 $1,543 - $4,714	2,757 Added 10.3%	29,517 $17,000
Q3 2021 Nov 02, 2021	SELL	$1.21 - $1.8 $2,693 - $4,006	-2,226 Reduced 7.68%	26,760 $44,000
Q2 2021 Aug 03, 2021	SELL	$1.56 - $1.98 $1,379 - $1,750	-884 Reduced 2.96%	28,986 $48,000
Q1 2021 May 04, 2021	BUY	$1.36 - $2.49 $991 - $1,815	729 Added 2.5%	29,870 $50,000
Q4 2020 Feb 01, 2021	BUY	$0.75 - $2.76 $2,280 - $8,390	3,040 Added 11.65%	29,141 $46,000
Q3 2020 Nov 09, 2020	BUY	$0.61 - $1.17 $197 - $377	323 Added 1.25%	26,101 $25,000
Q2 2020 Aug 07, 2020	BUY	$0.47 - $0.72 $93 - $143	199 Added 0.78%	25,778 $16,000
Q1 2020 May 04, 2020	SELL	$0.36 - $0.74 $301 - $620	-838 Reduced 3.17%	25,579 $11,000
Q4 2019 Feb 04, 2020	BUY	$0.35 - $0.58 $1,312 - $2,175	3,751 Added 16.55%	26,417 $18,000
Q3 2019 Nov 12, 2019	BUY	$0.38 - $0.52 $8,613 - $11,786	22,666 New	22,666 $11,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.